275 related articles for article (PubMed ID: 31587143)
1. Subcutaneous Injection of Drugs: Literature Review of Factors Influencing Pain Sensation at the Injection Site.
Usach I; Martinez R; Festini T; Peris JE
Adv Ther; 2019 Nov; 36(11):2986-2996. PubMed ID: 31587143
[TBL] [Abstract][Full Text] [Related]
2. Impact of Injection Speed, Volume, and Site on Pain Sensation.
Zijlstra E; Jahnke J; Fischer A; Kapitza C; Forst T
J Diabetes Sci Technol; 2018 Jan; 12(1):163-168. PubMed ID: 28990437
[TBL] [Abstract][Full Text] [Related]
3. Liquid growth hormone: preservatives and buffers.
Kappelgaard AM; Bojesen A; Skydsgaard K; Sjögren I; Laursen T
Horm Res; 2004; 62 Suppl 3():98-103. PubMed ID: 15539807
[TBL] [Abstract][Full Text] [Related]
4. Tolerability of hypertonic injectables.
Wang W
Int J Pharm; 2015 Jul; 490(1-2):308-15. PubMed ID: 26027488
[TBL] [Abstract][Full Text] [Related]
5. Subcutaneous Injection Site Pain of Formulation Matrices.
Shi GH; Pisupati K; Parker JG; Corvari VJ; Payne CD; Xu W; Collins DS; De Felippis MR
Pharm Res; 2021 May; 38(5):779-793. PubMed ID: 33942212
[TBL] [Abstract][Full Text] [Related]
6. Subcutaneous Injection Volume of Biopharmaceuticals-Pushing the Boundaries.
Mathaes R; Koulov A; Joerg S; Mahler HC
J Pharm Sci; 2016 Aug; 105(8):2255-9. PubMed ID: 27378678
[TBL] [Abstract][Full Text] [Related]
7. Impact of injection speed and volume on perceived pain during subcutaneous injections into the abdomen and thigh: a single-centre, randomized controlled trial.
Heise T; Nosek L; Dellweg S; Zijlstra E; Præstmark KA; Kildegaard J; Nielsen G; Sparre T
Diabetes Obes Metab; 2014 Oct; 16(10):971-6. PubMed ID: 24720741
[TBL] [Abstract][Full Text] [Related]
8. Physical interventions and injection techniques for reducing injection pain during routine childhood immunizations: systematic review of randomized controlled trials and quasi-randomized controlled trials.
Taddio A; Ilersich AL; Ipp M; Kikuta A; Shah V;
Clin Ther; 2009; 31 Suppl 2():S48-76. PubMed ID: 19781436
[TBL] [Abstract][Full Text] [Related]
9. A comparison of insulin injection needles on patients' perceptions of pain, handling, and acceptability: a randomized, open-label, crossover study in subjects with diabetes.
McKay M; Compion G; Lytzen L
Diabetes Technol Ther; 2009 Mar; 11(3):195-201. PubMed ID: 19267582
[TBL] [Abstract][Full Text] [Related]
10. Local tolerance of subcutaneous injections.
Fransson J; Espander-Jansson A
J Pharm Pharmacol; 1996 Oct; 48(10):1012-5. PubMed ID: 8953501
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of large volume subcutaneous injection tissue effects, pain, and acceptability in healthy adults.
Woodley WD; Morel DR; Sutter DE; Pettis RJ; Bolick NG
Clin Transl Sci; 2022 Jan; 15(1):92-104. PubMed ID: 34268888
[TBL] [Abstract][Full Text] [Related]
12. Acute Histopathologic Findings Related to Needle Puncture Trauma during Subcutaneous Injection in the Sprague-Dawley Rat Model.
Ramot Y; Kannan K; Reddy S; Krishnappa H; Dillberger JE; Nyska A
Toxicol Pathol; 2019 Jan; 47(1):93-96. PubMed ID: 30407145
[TBL] [Abstract][Full Text] [Related]
13. If Euhydric and Isotonic Do Not Work, What Are Acceptable pH and Osmolality for Parenteral Drug Dosage Forms?
Roethlisberger D; Mahler HC; Altenburger U; Pappenberger A
J Pharm Sci; 2017 Feb; 106(2):446-456. PubMed ID: 27889072
[TBL] [Abstract][Full Text] [Related]
14. Pain perception after subcutaneous injections of media containing different buffers.
Laursen T; Hansen B; Fisker S
Basic Clin Pharmacol Toxicol; 2006 Feb; 98(2):218-21. PubMed ID: 16445598
[TBL] [Abstract][Full Text] [Related]
15. Pain following controlled cutaneous insertion of needles with different diameters.
Arendt-Nielsen L; Egekvist H; Bjerring P
Somatosens Mot Res; 2006; 23(1-2):37-43. PubMed ID: 16846958
[TBL] [Abstract][Full Text] [Related]
16. New insight into the importance of formulation variables on parenteral growth hormone preparations: potential effect on the injection-site pain.
Taghizadeh B; Jaafari MR; Zarghami N
Front Endocrinol (Lausanne); 2022; 13():963336. PubMed ID: 36263321
[TBL] [Abstract][Full Text] [Related]
17. Clinical Evaluation of an Investigational 5 mL Wearable Injector in Healthy Human Subjects.
Woodley WD; Yue W; Morel DR; Lainesse A; Pettis RJ; Bolick NG
Clin Transl Sci; 2021 May; 14(3):859-869. PubMed ID: 33278331
[TBL] [Abstract][Full Text] [Related]
18. Randomized clinical trial to assess pain and bruising in medicines administered by means of subcutaneous and intramuscular needle injection: is it necessary to have needles changed?
Lamblet LC; Meira ES; Torres S; Ferreira BC; Martucchi SD
Rev Lat Am Enfermagem; 2011; 19(5):1063-71. PubMed ID: 22030569
[TBL] [Abstract][Full Text] [Related]
19. Influence of hypodermic needle dimensions on subcutaneous injection delivery--a pig study of injection deposition evaluated by CT scanning, histology, and backflow.
Juul KA; Bengtsson H; Eyving B; Kildegaard J; Lav S; Poulsen M; Serup J; Stallknecht B
Skin Res Technol; 2012 Nov; 18(4):447-55. PubMed ID: 22233448
[TBL] [Abstract][Full Text] [Related]
20. Can the upper inner side of the thigh become a new option for insulin injection?
Yuan J; Chen Y; Xuan Y; Cao L; Zhu J; Wang F; Zhou X; Ye Q; Liao L; Zheng Y; Zhou Q; Chen X; Chen M; Zhou W
Curr Med Res Opin; 2016 Jul; 32(7):1319-24. PubMed ID: 27090917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
